Provision for Loan Losses

Financial Term

Provision for Loan Losses (PLL) is a reserve that financial institutions set aside to cover potential losses that may arise from loans and other credit products. The purpose of the PLL is to provide a buffer against losses that inevitably occur in the process of lending money. Financial institutions use the PLL as a way to manage their credit risk exposure, which is the risk of loss that arises from borrowers defaulting on their loans.

In the financial industry, the PLL is typically calculated as a percentage of the outstanding loan balance. The percentage used is determined by the institution*s past experience with loan losses, economic conditions, and other factors. The greater the risk of loss, the higher the PLL percentage will be.

Once the PLL is established, it is allocated to specific loans or loan portfolios based on the risk level of each borrower. For example, loans to a borrower with a higher credit score and stronger financial standing may require a lower allocation from the PLL than loans to a borrower with a lower credit score and weaker financial standing.

When a borrower defaults on a loan, the loss is first deducted from the allocation from the PLL. If the loss exceeds the PLL allocation, the institution*s capital is used to cover the remaining balance. The institution then replenishes the PLL by setting aside additional reserves to cover potential future losses.

In summary, the Provision for Loan Losses is a financial industry term that refers to the reserve that financial institutions set aside to cover potential losses that may arise from loans and other credit products. This reserve is used to manage credit risk exposure and is allocated to specific loans or loan portfolios based on the risk level of each borrower. When a borrower defaults on a loan, the loss is first deducted from the allocation from the PLL and any remaining balance is covered by the institution*s capital.




Statement of Income

More Glossary Terms Beginning with P
  • Paediatric Exclusivity
    means, in the US, a six-month period of exclusivity to market a drug which is awarded by the FDA in return for certain paediatric clinical studies using that drug. This six-month period runs from the date of relevant patent expiry.
    Health Care Term Letter: P
  • Paid Development Method
    An actuarial method to estimate ultimate losses for a given cohort of claims such as an accident year/product line component. If the paid-to-date losses are then subtracted from the estimated ultimate losses, the result is an indication of the unpaid losses. The basic premise of the method is that cumulative paid losses for a given cohort of claims will grow in a stable, predictable pattern from y
    Insurance Term Letter: P
  • Panelboards
    Oriented strand board, particleboard, medium density fibreboard and plywood. Operating Statistics
    Manufacturing Term Letter: P
  • Partial Remission PR
    A decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment.
    Health Care Term Letter: P
  • Particleboard
    A panelboard produced by chemically bonding clean sawdust, small wood particles and recycled wood fibre under heat and pressure. Forestry & Wood Products Industry Operating Statistics
    Manufacturing Term Letter: P
  • Particulate Matter
    Total suspended particulate. A measure of the solid particles (wood, process dust and smoke) found in air emissions.
    Manufacturing Term Letter: P
  • Particulates
    Tiny particles of a substance.
    Manufacturing Term Letter: P
  • Passenger Load Factor
    Represents the total number of seats sold as a percentage of total seat capacity on all sectors flown. Airline Industry
    Transportation Term Letter: P
  • Passenger Mile Yield
    The amount of passenger revenue earned per revenue passenger mile during a reporting period Airline Industry
    Transportation Term Letter: P
  • Passenger revenue yield per Mile Average Yield per RPM
    Represents the average scheduled passenger fare revenue for each revenue passenger mile (RPM), or each mile a scheduled revenue passenger is flown. Airline Industry
    Transportation Term Letter: P
  • Passive Immunotherapy
    Immunologically active material transferred into the patient as a passive recipient. Monoclonal antibodies are considered Passive Immunotherapy since antibodies are generated outside the body and given to the patient
    Health Care Term Letter: P
  • Patent Term Extension
    means an extension of up to five years in the term of a US patent relating to a drug which compensates for delays in marketing resulting from the need to obtain FDA approval.
    Health Care Term Letter: P
Get Provision for Loan Losses's full dataset: Subscribe API License